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Abstract
Bacterial vaginosis (BV) is a difficult-to-treat recurrent condition in which health-associated
lactobacilli are outnumbered by other anaerobic bacteria, such as Gardnerella vaginalis.
Certain genotypes of G. vaginalis can produce sialidase, while others cannot. Sialidase is
known to facilitate the destruction of the protective mucus layer on the vaginal epithelium by
hydrolysis of sialic acid on the glycans of mucous membranes. This process possibly facili-
tates adhesion of bacterial cells on the epithelium since it has been linked with the develop-
ment of biofilm in other pathogenic conditions. Although it has not been demonstrated yet, it
is probable that G. vaginalis benefits from this mechanism by attaching to the vaginal epithe-
lium to initiate biofilm development. In this study, using vaginal specimens of 120 women
enrolled in the Ring Plus study, we assessed the association between the putative G. vagi-
nalis sialidase A gene by quantitative polymerase chain reaction (qPCR), the diagnosis of
BV according to Nugent score, and the occurrence of a BV-associated biofilm dominated by
G. vaginalis by fluorescence in situ hybridisation (FISH). We detected the putative sialidase
A gene in 75% of the G. vaginalis-positive vaginal specimens and found a strong association
(p<0.001) between the presence of a G. vaginalis biofilm, the diagnosis of BV according to
Nugent and the detection of high loads of the G. vaginalis sialidase A gene in the vaginal
specimens. These results could redefine diagnosis of BV, and in addition might guide
research for new treatment.
Introduction
Gardnerella vaginalis has consistently been found in bacterial vaginosis (BV) [1–3], a dysbiosis
of the vaginal econiche in which the health-associated lactobacilli are outnumbered by other
aerotolerant and anaerobic organisms. It has been demonstrated that a vaginal mucosa poly-
microbial biofilm is associated with BV [4,5]. G. vaginalis is able to adhere to the vaginal
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epithelial cells and subsequently develop a biofilm on the vaginal wall [4,5], a mechanism that
possibly increases the tolerance of G. vaginalis to lactic acid and hydrogen peroxide produced
by lactobacilli [6] and to antimicrobial treatment [7,8]. It has been suggested that G. vaginalis
initiates the colonisation of the vaginal mucosa and acts as a scaffold to which other species
subsequently can attach [6,9,10]. However, G. vaginalis can also occur in the healthy vaginal
microbiome (although in lower concentrations) [1,2,11], suggesting that the mere presence of
G. vaginalis does not necessarily result in biofilm formation and BV. This observation has led
several researchers to hypothesise that different types of G. vaginalis with different virulence
potentials might exist [12–14].
Certain G. vaginalis genotypes can produce sialidase, also known as neuraminidase [13].
Sialidase is an enzyme that cleaves sialic acid from terminal glycans of glycoproteins, which are
also present in the cervicovaginal fluid [15]. Sialidases have been studied in many contexts of
bacterial pathogenesis, and these studies provide several examples of possible mechanisms by
which these enzymes could also act in the pathogenesis of BV. In general, the production of
sialidase is a common virulence factor in pathogens such as the Influenza virus [16] and a large
number of bacterial species, such as Propionibacterium acnes [17], Pseudomonas aeruginosa
[18], Streptococcus pneumoniae [19] and Vibrio cholerae [20]. Furthermore, sialidase has been
strongly linked with bacterial biofilm development [21–23]. Cleaving off sialic acid by sialidase
provides bacteria with free sialic acid that can serve as a nutrient [24], and the exposure of the
underlying glycan-binding site facilitates adhesion of bacterial cells [25,26]. In addition, it has
been suggested that, by incorporation of the cleaved sialic acids into bacterial cell-surface
structures, bacteria could disguise themselves as host cells and bypass the host’s immune
response [26,27]. Increased sialidase activity has been detected in the vaginal fluid of BV
patients [28,29], and is the basis of a marketed quick test for diagnosis of BV [30]. It has been
demonstrated that sialidase facilitates the destruction of the protective mucus layer in the
vagina [31] and increases the proteolysis of innate immune factors such as secretory IgA [15].
Although it has not been demonstrated yet, it is probable that G. vaginalis benefits from this
mechanism by attaching to the vaginal epithelium to initiate biofilm development. Although
other BV-associated bacteria (e.g. Prevotella and Bacteroides species) have also been shown to
produce sialidase in the vagina [28], G. vaginalis is most frequently isolated, in high concentra-
tions, from vaginal fluid of women with BV [1–3] and has a higher tendency to adhere to vagi-
nal epithelial cells compared to other BV-associated anaerobes [6]. We hypothesised that, like
other species [21–23], the genotypes of G. vaginalis that contain the putative sialidase A gene
are associated with the presence of vaginal biofilms, leading to BV. Therefore, we assessed the
association between the presence of the putative sialidase A gene in G. vaginalis and the occur-
rence of BV-associated G. vaginalis biofilm in vaginal samples of women with and without BV.
Methods and materials
Study participants and ethics statement
Vaginal samples were collected from 120 Rwandan women participating in a study on the
acceptability of using an intravaginal ring for contraception (NuvaRing1, Merck, New Jersey,
USA) and its effect on the vaginal microbiome (the Ring Plus project [32]). Participants
were between 18 and 35 years old and provided written informed consent for participation in
the study. The Ring Plus project was approved by the Rwanda National Ethics Committee
(Approval number 481/RNEC/2013); and the ethics committees of the Institute of Tropical
Medicine (ITM), Belgium (Approval number 864/13); the Antwerp University Hospital, Bel-
gium (Approval number 13/7/85); and the University of Liverpool, UK (Approval number
RETG000639IREC).
Association of Gardnerella vaginalis sialidase A gene with bacterial vaginosis biofilm
PLOS ONE | DOI:10.1371/journal.pone.0172522 February 27, 2017 2 / 11
Trials Partnership (EDCTP) through a project
entitled ‘Preparing for clinical trials with vaginal
rings that protect women from HIV and unintended
pregnancy’ (grant code SP.2011.41304.043)
(received by TC). The funder had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
Vaginal sample collection
Vaginal samples were collected at the enrolment visit and at each ring removal visit by the
study clinician. Two Copan flocked1 swabs (Copan, Brescia, Italy) and one cotton swab
were brushed against the lateral walls of the vagina. The cotton swab was immediately used
to prepare two vaginal slides: one for Gram staining and one for fluorescence in situ hybri-
disation (FISH) on a Superfrost Plus1 slide (Menzel-Gla¨ser, Braunschweig, Germany).
Both were heat-fixed by passing twice through a flame. The Superfrost Plus1 slides were
stored and shipped at room temperature to the ITM, where they were fixed for a second
time using Carnoy solution (6:3:1, ethanol:chloroform:glacial acetic acid) [5] for 12 hours
minimum. The Copan flocked1 swabs were eluted by vortexing for at least 15 seconds in
1.2 ml of diluted phosphate buffered saline (PBS) (pH 7.4–1:9, PBS:saline). The eluates were
stored at -80˚C until shipment and shipped to the ITM using a temperature-controlled dry
shipper.
Laboratory methods
Nugent score. The status of the vaginal microbiome was assessed at the Rinda Ubuzima
laboratory (Kigali, Rwanda) by Nugent scoring of a Gram stained vaginal slide [33]. A score of
0–3 was considered as normal vaginal microbiome; a score of 4–6 as intermediate vaginal
microbiome and a score of 7–10 as BV.
Peptide nucleic acid fluorescence in situ hybridisation. Peptide nucleic acid (PNA)
FISH on the vaginal slides using a species-specific probe for G. vaginalis (Gard162) and the
broad-range BacUni-1 probe and imaging was performed as described earlier [5]. Separate
scattered bacterial cells were defined as dispersed bacteria. Aggregates of bacterial cells, stick-
ing to the vaginal epithelial cells, were defined as adherent bacteria forming a biofilm.
Quantitative polymerase chain reaction for Gardnerella vaginalis. DNA was extracted
from 250 μl of the vaginal swab eluate using the Abbott m2000sp automated extraction plat-
form (Abbott, Maidenhead, UK), according to the manufacturer’s instructions. The volume of
200 μl DNA extract was stored at –80˚C until testing. qPCR was performed for each bacteria
species separately, to avoid competition between the primers. The 25 μl PCR mixture con-
tained 12.5 μl Rotor-Gene SYBR Green RT-PCR Master mix (Qiagen, Venlo, the Netherlands),
5 μl DNA extract, 1 μM of G. vaginalis forward and reverse primers targeting the 16S rRNA
(Integrated DNA Technologies, Leuven, Belgium) and RNase-free water provided with the
Rotor- Gene SYBR Green PCR kit. The primers for G. vaginalis and the amplification reactions
(Rotor Gene Q MDx 5 plex, Qiagen) have been described before [5,11].
Quantification was done using standard curves, constructed using DNA extracts from
G. vaginalis (LMG 7832T), grown at 35˚C ± 2˚C on Columbia agar base (Becton Dickinson) +
5% horse blood, under anaerobic conditions. DNA concentrations were determined using
NanoDrop (Thermo Fisher Scientific, Erembodegem, Belgium) and the number of genomes
was calculated using the described genome sizes and G+C content of the strains. A total of six
tenfold dilutions of the DNA stocks were prepared in high performance liquid chromatogra-
phy (HPLC) grade water. Both the standard curve and samples were run in duplicate. The bac-
terial load was expressed as genome equivalents (geq)/ml.
Quantitative polymerase chain reaction for the putative Gardnerella vaginalis sialidase
A gene. The design of the primer set for amplification of the putative G. vaginalis sialidase A
gene was based on previous work by Lopes dos Santos Santiago et al. [13] and on the sequence
of sialidase A (NZ_ ACGF02000001.1) from the fully sequenced G. vaginalis ATCC 14019
strain (reference genome for the Human Microbiome Project, Baylor College of Medicine,
Houston, TX). It should be noted that although the G. vaginalis ATCC 14019 reference strain
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originates from a woman diagnosed with BV and includes the putative sialidase A gene, it does
not produce sialidase in laboratory cultures [31,34].
The previously designed G. vaginalis sialidase forward primer (GVSI Forward, 5’-GAC
GACGGCGAATGGCACGA-3’)[13] was combined with an updated reverse primer (GVSI
Reverse2, 5’-TACAAGCGGCTTTACTCTTG-3’), designed using Primer Blast (National
Center for Biotechnology Information, Bethesda, MD) to eliminate the occurrence of primer
dimers. The putative G. vaginalis sialidase A gene amplification was restricted to the vaginal
samples containing G. vaginalis as defined by the above described qPCR. The 25 μl PCR mix-
ture contained 12.5 μl Rotor-Gene SYBR Green qPCR Master mix (Qiagen, Venlo, the Nether-
lands), 5 μl DNA extract, 0.75 μM of 5 μM G. vaginalis sialidase forward and reverse primers
(Integrated DNA Technologies, Leuven, Belgium) and RNase-free water provided with the
Rotor-Gene SYBR Green PCR kit.
The amplification reactions were performed using the Rotor Gene Q MDx 5 plex (Qiagen,
Venlo, the Netherlands) and the amplification program (10 min 95˚C, (5 sec 95˚C– 10 sec
58˚C) x 45) was followed by melting curve analysis. Each sample was run in duplicate and each
run included a standard curve. An exhaustive validation of the qPCR protocol (S1 Appendix)
demonstrated that the putative G. vaginalis sialidase A gene qPCR was sensitive and specific
for G. vaginalis.
Statistical analysis
Laboratory analysis was performed blinded to all other data, except for the qPCR of the puta-
tive sialidase A gene which was performed on vaginal samples containing G. vaginalis accord-
ing to qPCR.
Bacterial counts were log 10 transformed before analysis. Data analysis was done using
STATA13. The p-values reported for associations between the presence and quantity of the sia-
lidase gene and BV/qPCR-biofilm results were obtained using mixed effects ordered logistic
regression.
Results
Characterisation of vaginal samples
A total of 527 samples were available for Nugent scoring, 462 samples were analysed by FISH
and 528 samples were used for qPCR to detect G. vaginalis. All 393 G. vaginalis qPCR-positive
samples were tested for the presence of the putative G. vaginalis sialidase A gene by qPCR (Fig
1, Table 1).
Nugent score. Of the total of 527 samples of 120 participants, 299 (56.7%) showed a
healthy microbiome (Nugent score 0–3), 53 (10.1%) were categorised as intermediate (Nugent
score 4–6) and 175 (33.2%) were diagnosed as BV (Nugent score 7–10).
Fluorescence in situ hybridisation. A subset of 462 samples was analysed with FISH. The
remaining 65 samples could not be analysed mainly due to the absence of epithelial cells and bac-
teria on the slides. G. vaginalis was present in 290 samples (62.8%) using FISH. In 191 of 290 vagi-
nal slides (65.9%), aggregated bacteria were attached to the vaginal epithelium and considered to
be part of a biofilm, although dispersed bacteria were present as well (Fig 2). In the remaining 99
vaginal slides (34.1%), G. vaginalis was only present in the planktonic/dispersed form.
Quantitative polymerase chain reaction. A total of 528 samples were available for molec-
ular quantification of G. vaginalis genome equivalents. G. vaginalis was detected in 393 samples
(74.4%), with a mean bacterial load (log 10) of 6.97 ± 1.37 (standard deviation) geq/ml. More-
over, the presence of the putative G. vaginalis sialidase A gene was assessed in all 393 G. vagina-
lis-qPCR positive samples and was detected in 294 samples (74.8%). The putative G. vaginalis
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sialidase A gene concentration was <106 geq/ml (low load) in 112 samples (28.5%) and 106
geq/ml (high load) in the remaining 182 samples (46.3%).
Association between the presence of G. vaginalis, BV and biofilm
according to FISH
The presence of G. vaginalis in the sample, as assessed by qPCR, was associated with the diag-
nosis of BV and presence of G. vaginalis biofilm, as assessed with FISH (p<0.001) (Table 2). A
Fig 1. Overview of different subsets of samples analysed with fluorescence in situ hybridisation (n = 462), Nugent score
(n = 527), G. vaginalis quantitative polymerase chain reaction (n = 528) and G. vaginalis sialidase quantitative polymerase chain
reaction (n = 393).
doi:10.1371/journal.pone.0172522.g001
Table 1. Characteristics of vaginal samples.
Test Total Result N(%)
Nugent score 527 0–3 299 (56.7)
4–6 53 (10.1)
7–10 175 (33.2)
Fluorescence in situ hybridisation 462 Gardnerella vaginalis positive 290 (62.8)
G. vaginalis biofilm 191 (41.3)
G. vaginalis dispersed only 99 (21.4)
Quantitative polymerase chain reaction 528 G. vaginalis positive 393 (74.4)
393 G. vaginalis sialidase positive 294 (74.8)
doi:10.1371/journal.pone.0172522.t001
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higher concentration of G. vaginalis in the sample was associated with the diagnosis of BV and
the presence of G. vaginalis biofilm.
Association between the presence of the putative G. vaginalis sialidase
A gene and biofilm
Both FISH and G. vaginalis sialidase A qPCR analysis were carried out for a subset of 345 sam-
ples containing G. vaginalis as assessed by qPCR. Based on our data, the presence of the G.
vaginalis sialidase A gene, as assessed by qPCR, was associated with the presence of G. vaginalis
Fig 2. Superimposed confocal laser scanning microscopy images with 400x magnification of Gardnerella vaginalis biofilm, in three vaginal
samples: vaginal epithelial cells DAPI in blue and G. vaginalis specific PNA-probe Gard162 with Alexa Fluor 647 in red. 2A shows an example of
dispersed-only G. vaginalis (negative for biofilm), 2B shows a light G. vaginalis biofilm (a small number of bacteria are adhering to the vaginal epithelial cells)
and 2C is an example of a heavy G. vaginalis biofilm (the vaginal epithelial cells are covered by bacteria).
doi:10.1371/journal.pone.0172522.g002
Table 2. The association between quantitative polymerase chain reaction results for G. vaginalis and G. vaginalis sialidase of vaginal samples
and fluorescence in situ hybridisation and Nugent score results of vaginal slides.
Gardnerella
vaginalis 0 geq/
ml1 N (%)
G. vaginalis >0
and <106(geq/
ml)N (%)
G. vaginalis106
geq/ml N (%)
P-
value3
G. vaginalis
sialidase 0 geq/
ml N (%)
G. vaginalis
sialidase >0 and
<106(geq/ml N (%)
G. vaginalis
sialidase 106
geq/ml N (%)
P-
value
FISH2 G.
vaginalis
116 (100) 97 (100) 248 (100) <0.001 86 (100) 96 (100) 163 (100) <0.001
G. vaginalis
absent
75 (64.7) 58 (59.8) 38 (15.3) 47 (54.7) 33 (34.4) 16 (9.8)
G. vaginalis
dispersed
only
23 (19.8) 23 (23.7) 53 (21.4) 24 (27.9) 28 (29.2) 24 (14.7)
G. vaginalis
biofilm
18 (15.5) 16 (16.5) 157 (63.3) 15 (17.4) 35 (36.5) 123 (75.5)
Nugent score 135 (100) 109 (100) 282 (100) <0.001 98 (100) 112 (100) 181 (100) <0.001
Nugent 0–3 120 (88.9) 98 (89.9) 80 (28.4) 80 (81.6) 61 (54.5) 37 (20.4)
Nugent 4–6 3 (2.2) 5 (4.6) 45 (15.9) 8 (8.2) 14 (12.5) 28 (15.5)
Nugent 7–10 12 (8.9) 6 (5.5) 157 (55.7) 10 (10.2) 37 (33.0) 116 (64.1)
1 geq/ml = genome equivalent/ml; results from quantitative polymerase chain reaction.
2 FISH: Fluorescence in situ hybridisation.
3 P-values obtained by mixed effects ordered logistic regression.
doi:10.1371/journal.pone.0172522.t002
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biofilm, as assessed with FISH (p<0.001) (Table 2). For the 163 samples with a high load of G.
vaginalis harbouring the sialidase A gene (i.e.106 geq/ml), G. vaginalis biofilm was present
in 75.5%, whereas dispersed-only G. vaginalis was present in 14.7% of the samples. Using
FISH, G. vaginalis was not visualised in 9.8% of these samples. In the 96 samples with a low
load of G. vaginalis harbouring the sialidase A gene (<106 geq/ml), a more equal distribution
between the three categories was observed; with 36.5% samples with visible biofilm, 29.2%
samples with only dispersed G. vaginalis and 34.4% samples with no G. vaginalis observed by
FISH. Out of the 86 samples without putative G. vaginalis sialidase A gene as assessed by
qPCR, G. vaginalis biofilm was detected using FISH in 17.4% of the samples, while in 27.9%
samples only dispersed/planktonic G. vaginalis were seen. G. vaginalis was not observed in
54.7% of the samples.
Association between the presence of the putative G. vaginalis sialidase
A gene and the diagnosis of bacterial vaginosis
A subset of 391 samples was analysed by both Nugent scoring and putative G. vaginalis sialidase
A gene qPCR. The probability of having BV according to Nugent is increased when the putative
G. vaginalis sialidase A gene is present in high loads ( 106 geq/ml) (p<0.001) (Table 2). Of the
181 samples with a high load of the putative G. vaginalis sialidase A gene, 64.1% were BV-posi-
tive (Nugent score 7–10), 20.4% had a healthy vaginal microbiome (Nugent score of 0–3) and
15.5% were diagnosed with an intermediate Nugent score of 4–6. In contrast, BV was diagnosed
in 10 out of the 98 samples (10.2%) in which no putative G. vaginalis sialidase A gene could be
detected. However, 80 of 98 (81.6%) samples represented a healthy vaginal microbiome accord-
ing to Nugent and 8 of 98 samples (8.2%) had an intermediate score. Additionally, when the
putative G. vaginalis sialidase A gene was present in low amounts (<106 geq/ml), 54.5% of the
112 samples were considered healthy according to the Nugent score, 33.0% were categorised as
BV, and 12.5% represented an intermediate vaginal microbiome.
Discussion
BV is the most prevalent vaginal disorder in women of reproductive age worldwide, and aside
from the discomfort in case of symptomatic BV, it can also generate an array of serious gynae-
cological and obstetric complications. The presence of BV-associated anaerobes in the vaginal
environment increases the risk for preterm labour and birth [35]. Furthermore, the presence
of sialidase in vaginal fluid has been linked to BV and to preterm birth as well [36,37]. In a
large cohort of 1806 women that included 800 women with BV and 53 spontaneous preterm
births, Cauci et al. [37] showed that the sialidase levels in the vaginal fluid were significantly
associated with all adverse pregnancy outcomes.
G. vaginalis plays an important role in BV, since G. vaginalis overgrowth is found in nearly
all cases of BV [38]. However, the presence of G. vaginalis in healthy vaginal environments
[11,39] contradicts its pathogenic role in BV. To resolve this discrepancy, it has been suggested
that G. vaginalis might actually consist of different subspecies with distinct roles in BV
pathogenesis, which is supported by the genotypic and phenotypic diversity of the species
[14,34,40]. Although other BV-associated bacteria (e.g. Prevotella and Bacteroides species) are
able to produce sialidase [28], we decided to investigate G. vaginalis sialidase in BV, consider-
ing that G. vaginalis is most frequently isolated from vaginal fluids of women suffering from
BV [1–3,38] and that it has a higher tendency to adhere to vaginal epithelial cells in vitro com-
pared to other BV-associated anaerobes [6]. We studied the association between the presence
of the putative G. vaginalis sialidase A gene, as a proxy for sialidase production, in the vagina
and the occurrence of BV and bacterial biofilm on the vaginal epithelium. To this end, we
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screened vaginal samples of 120 Rwandan women [32] by means of a putative G. vaginalis siali-
dase A specific qPCR and assessed the occurrence of BV by means of Nugent scoring and of
biofilm by confocal laser scanning microscopy (CLSM) after FISH for G. vaginalis on vaginal
samples.
In this population, the putative G. vaginalis sialidase A gene was detected in about 75% of the
G. vaginalis-positive samples. In about 60% of those samples, a high load (106 geq/ml) of the
gene was detected. This high prevalence of the G. vaginalis sialidase A gene in our study may be
explained by the cohort of women enrolled for this study and the high prevalence of vaginal dys-
biosis, i.e. in 43.3% of all samples. Earlier studies have investigated the presence of the G. vagina-
lis sialidase gene and the production of sialidase in cultured isolates [13,28,41,42]. Using clinical
isolates from Belgian women, Lopes dos Santos Santiago and colleagues [13] detected the G.
vaginalis sialidase A gene using qPCR in 51% of the strains. When using the filter paper spot
test for the detection of sialidase activity, von Nicolai et al. [41] could detect sialidase production
in only 1 of 10 clinical isolates. Additionally, Briselden et al. [28] detected sialidase activity in
20% of 105 G. vaginalis isolates with no difference in isolates from women with and without
BV), and Moncla and Pryke [42] observed sialidase activity in 39% of 31 isolates.
At present, it is not clear whether the sialidase gene is expressed constitutively or not. Pleck-
aityte and colleagues [43] detected a sialidase gene in 17 tested G. vaginalis isolates, but only 10
of these strains actually produced sialidase in vitro. Schellenberg et al. [34] also found that the
gene presence was not predictive of actual sialidase activity using a filter spot assay: out of 77
G. vaginalis isolates positive for the sialidase gene, 36 produced sialidase. In addition, almost
all these sialidase-producers [33] belonged to the same chaperonin-60 universal target-based
molecular subgroup, a group that consisted solely of sialidase-producers [34]. In currently
ongoing (not yet published) in vitro experiments by our group, we found that only 29 out of
41 sialidase A gene- positive G. vaginalis isolates produced sialidase, based on the filter spot
test. Interestingly, we noticed that all but two sialidase-producing strains were isolated from
women with BV according to Nugent. This contradicts what was published by Lopes dos San-
tos Santiago et al. [13] who found a 100% correspondence between the mere presence of the
gene and sialidase activity in 19 G. vaginalis isolates. However, all but one of these isolates were
obtained from women with a disturbed microbiome, which might have introduced a bias [13].
The absence of sialidase activity in G. vaginalis isolates containing the sialidase gene might be
explained by the absence of an alternative gene encoding this activity or the need for other fac-
tors to stimulate the expression of the gene. The presence of sialic acid on epithelial cells might
be a possible trigger that activates the sialidase gene and subsequent production of sialidase. It
could also be possible that a threshold in G. vaginalis concentration needs to be reached in
order to activate the sialidase gene. In any case, more basic research is needed to fully under-
stand the sialidase expression pathway.
When looking at the association between the presence of the G. vaginalis and its sialidase
gene and the diagnosis of BV by Nugent score, we found that the probability for having BV
(Nugent score 7–10) was increased when a high concentration of G. vaginalis and its putative sia-
lidase A gene was present in the vaginal samples. This was expected, since sialidase production
by G. vaginalis is recognised as a virulence factor [43], and has already been associated with BV
[37]. In our previous work [5], we confirmed the importance of G. vaginalis in the development
of a biofilm on the vaginal epithelium in BV, as established by Swidsinski et al. [4] in 2005.
Ours was the first study to use clinical samples to demonstrate the significance of G. vagina-
lis’ potential ability to produce sialidase and to document its association with BV and vaginal
biofilm. We established a strong association between a high load of the putative G. vaginalis
sialidase A gene, as measured by a specific qPCR, and G. vaginalis being part of a vaginal epi-
thelium biofilm, visualised by CLSM after FISH. Sialidase has been linked with biofilm
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development in other microorganisms. In Pseudomonas aeruginosa, sialidase (or neuramini-
dase) contributes to the initial colonisation of the airway, and colonisation could be blocked in
vitro by viral neuraminidase inhibitors [21]. Likewise in pneumococcal infections, sialidase is
involved in biofilm formation and pathogenesis of respiratory tract infections [22,23]. Also,
sialidase producing Propionibacterium acnes isolates were more associated with acne than siali-
dase negative isolates [44].
A shortcoming of this study is the absence of isolates. Clinical isolates would have provided
valuable information on ARDRA genotyping and the actual sialidase activity. Being able to
assess sialidase production by G. vaginalis directly in our Ring Plus samples would have been
interesting, but since sialidase activity in the vaginal samples could also have resulted from
other vaginal bacterial species, it would have confounded the results. Despite this limitation,
we were able to establish that the potential ability of G. vaginalis to produce sialidase is linked
to the presence of BV and the existence of a vaginal G. vaginalis biofilm. This finding may
improve BV diagnosis, but it may also guide future research for new and better treatments for
this recurrent and difficult-to-treat condition. Future studies should investigate biofilm-for-
mation linked to sialidase-production in different subtypes of G. vaginalis.
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